Researchers at the University of Queensland in Australia are studying the anti-bacterial properties of cannabidiol in hopes of creating commercially viable antimicrobial treatments, particularly ones effective against bacteria resistant to current conventional medicines.
In the case of gram-negative infections, there have essentially been no novel molecular classes discovered and approved for clinical use for more than 50 years.
“This is the first time CBD has been shown to kill some types of Gram-negative bacteria,” said UQ Institute for Molecular Bioscience’s Associate Professor Mark Blaskovich. “These bacteria have an extra outer membrane, an additional line of defense that makes it harder for antibiotics to penetrate.”
Previous research from the project indicated cannabidiol could kill gram-positive bacteria, including Staphylococcus aureus, which is responsible for staph infections.
As well as a stand-alone treatment, other research has found combining CBD and antibiotics produces a more powerful effect than using with antibiotics alone.
You can read more here.